Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Stem and progenitor cell-mediated tumor selective gene therapy.

Aboody KS, Najbauer J, Danks MK.

Gene Ther. 2008 May;15(10):739-52. doi: 10.1038/gt.2008.41. Epub 2008 Mar 27. Review. Erratum in: Gene Ther. 2008 Jul;15(14):1072.

PMID:
18369324
2.

[Mesenchymal stem cells as an antitumor therapy tool].

Karshieva SSh, Krasikov LS, Beliavskiĭ AV.

Mol Biol (Mosk). 2013 Jan-Feb;47(1):50-60. Review. Russian.

3.

Gene recombinant bone marrow mesenchymal stem cells as a tumor-targeted suicide gene delivery vehicle in pulmonary metastasis therapy using non-viral transfection.

Zhang TY, Huang B, Yuan ZY, Hu YL, Tabata Y, Gao JQ.

Nanomedicine. 2014 Jan;10(1):257-67. doi: 10.1016/j.nano.2013.06.003. Epub 2013 Jun 12.

PMID:
23770065
4.

Harnessing mesenchymal stem cell homing as an anticancer therapy.

Hagenhoff A, Bruns CJ, Zhao Y, von Lüttichau I, Niess H, Spitzweg C, Nelson PJ.

Expert Opin Biol Ther. 2016 Sep;16(9):1079-92. doi: 10.1080/14712598.2016.1196179. Epub 2016 Jun 13. Review.

PMID:
27270211
6.

Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy.

Sasportas LS, Kasmieh R, Wakimoto H, Hingtgen S, van de Water JA, Mohapatra G, Figueiredo JL, Martuza RL, Weissleder R, Shah K.

Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4822-7. doi: 10.1073/pnas.0806647106. Epub 2009 Mar 5.

7.

Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.

Brown AB, Yang W, Schmidt NO, Carroll R, Leishear KK, Rainov NG, Black PM, Breakefield XO, Aboody KS.

Hum Gene Ther. 2003 Dec 10;14(18):1777-85.

PMID:
14670128
8.

A gene delivery system with a human artificial chromosome vector based on migration of mesenchymal stem cells towards human glioblastoma HTB14 cells.

Kinoshita Y, Kamitani H, Mamun MH, Wasita B, Kazuki Y, Hiratsuka M, Oshimura M, Watanabe T.

Neurol Res. 2010 May;32(4):429-37. doi: 10.1179/174313209X455718. Epub 2009 Jul 8.

PMID:
19589205
9.

Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.

Kim SK, Kim SU, Park IH, Bang JH, Aboody KS, Wang KC, Cho BK, Kim M, Menon LG, Black PM, Carroll RS.

Clin Cancer Res. 2006 Sep 15;12(18):5550-6.

10.

Development of a tumor-selective approach to treat metastatic cancer.

Aboody KS, Bush RA, Garcia E, Metz MZ, Najbauer J, Justus KA, Phelps DA, Remack JS, Yoon KJ, Gillespie S, Kim SU, Glackin CA, Potter PM, Danks MK.

PLoS One. 2006 Dec 20;1:e23.

11.

Mesenchymal stem cells as cellular vehicles for prodrug gene therapy against tumors.

Amara I, Touati W, Beaune P, de Waziers I.

Biochimie. 2014 Oct;105:4-11. doi: 10.1016/j.biochi.2014.06.016. Epub 2014 Jun 27. Review.

PMID:
24977933
12.

Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.

Kim SM, Lim JY, Park SI, Jeong CH, Oh JH, Jeong M, Oh W, Park SH, Sung YC, Jeun SS.

Cancer Res. 2008 Dec 1;68(23):9614-23. doi: 10.1158/0008-5472.CAN-08-0451.

13.

Therapeutic gene products delivery by neuron stem cells.

Tan J, Meng Y, Huang S, Wang P.

Curr Pharm Biotechnol. 2012 Sep;13(12):2427-31. Review.

PMID:
23016647
14.

Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma.

Altanerova V, Cihova M, Babic M, Rychly B, Ondicova K, Mravec B, Altaner C.

Int J Cancer. 2012 May 15;130(10):2455-63. doi: 10.1002/ijc.26278. Epub 2011 Aug 24.

15.

Neural stem cell-based gene therapy for brain tumors.

Kim SU.

Stem Cell Rev. 2011 Mar;7(1):130-40. doi: 10.1007/s12015-010-9154-1.

PMID:
20521177
16.

Mesenchymal stem cells expressing therapeutic genes induce autochthonous prostate tumour regression.

Abrate A, Buono R, Canu T, Esposito A, Del Maschio A, Lucianò R, Bettiga A, Colciago G, Guazzoni G, Benigni F, Hedlund P, Altaner C, Montorsi F, Cavarretta IT.

Eur J Cancer. 2014 Sep;50(14):2478-88. doi: 10.1016/j.ejca.2014.06.014. Epub 2014 Jul 21.

PMID:
25060826
17.

Stem cell based cancer gene therapy.

Cihova M, Altanerova V, Altaner C.

Mol Pharm. 2011 Oct 3;8(5):1480-7. doi: 10.1021/mp200151a. Epub 2011 Jul 25. Review.

PMID:
21755953
18.
19.

Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC/5FC therapy in human melanoma xenograft model.

Kucerova L, Skolekova S, Demkova L, Bohovic R, Matuskova M.

Gene Ther. 2014 Oct;21(10):874-87. doi: 10.1038/gt.2014.66. Epub 2014 Jul 24.

PMID:
25056607
20.

Supplemental Content

Support Center